Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Financial results as ....
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes (India) Ltd has informed the stock exchanges that a meeting of its Board of Directors is scheduled for Thursday, 13 November 2025. The Board will consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September 2025. The trading window for insiders is already closed since 30 September 2025 and will reopen on 16 November 2025. The intimation is filed under Regulation 29 and 33 of the SEBI Listing Regulations, 2015. No actual financial numbers have been disclosed in this filing; it is purely a notice of the upcoming board meeting.
No immediate impact on shareholders — this is a routine regulatory intimation ahead of the Q2 FY26 results. Investors should watch for the actual results announcement on or after 13 November 2025 to assess the company's performance.